Neurogenic locus notch homolog protein 1 mRNA 3'-untranslated region (NOTCH1 mRNA 3'-UTR)

The Neurogenic locus notch homolog protein 1 (NOTCH1) mRNA 3'-untranslated region (3'-UTR) is a critical non-coding segment of the NOTCH1 transcript that regulates gene expression post-transcriptionally. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that control the stability and translation of the mRNA. In several cancers, particularly chronic lymphocytic leukemia (CLL), recurrent mutations or deletions in the 3'-UTR disrupt these regulatory sites, leading to the stabilization of the transcript and constitutive overexpression of the NOTCH1 receptor. This overexpression drives oncogenic signaling pathways that promote cell proliferation and survival. Therapeutic strategies targeting the NOTCH1 3'-UTR involve the use of miRNA mimics or antisense oligonucleotides designed to restore translational repression or trigger mRNA degradation. While these approaches offer a more targeted alternative to broad-spectrum gamma-secretase inhibitors, challenges remain regarding tissue-specific delivery and the management of toxicities associated with systemic Notch pathway modulation.

Other names

NOTCH1 3'-UTRNotch 1 mRNA 3'-untranslated regionhNOTCH1 3'-UTRNOTCH1 3-prime untranslated region

Drugs targeting this region typically utilize RNA interference (RNAi) or antisense inhibition to induce mRNA degradation or block translation, thereby reducing the expression of the oncogenic NOTCH1 protein.